Dr Teo Ching Ching Melissa
General Surgeon
Specialty
General Surgery
Languages
English, Hokkien, Mandarin, Teochew
Gender
Female
Insurance Panel
Singlife, Prudential^
Please check with your insurance provider for more information, and for their most up-to-date list of panel doctors.
^Specialists may qualify to be on the Extended Panel (EP). You may enjoy selected panel benefits depending on your policy and riders.
Key achievements
- Performed more than 10,000 gastroscopies and colonoscopies
- Headed the division of surgical oncology at the National Cancer Centre Singapore (NCCS) from 2015 to 2019
- Headed and started the Centre for Peritoneal and Pelvic Disease at NCCS
- Authored more than 250 peer-reviewed publications and 6 book chapters
Experience
Dr Melissa Teo is a general surgeon and surgical oncologist at Mount Elizabeth Novena Hospital, Singapore.
She has expertise in cancer of the colon and rectal, lower gastrointestinal cancers and surgical oncology, and has treated complex abdominal, pelvic and peritoneal cases in Southeast Asia.
She has experience in the management of peritoneal disease (Cytoreductive Hyperthermic Intraperitoneal Chemotherapy (CRS HIPEC)) in Southeast Asia and is the president of the Asian Peritoneal Surface Malignancy Group (ASPMG).
She is a senior consultant and the former head of the division of the surgical oncology at the National Cancer Centre Singapore (NCCS). She started and headed NCCS’ Centre of Peritoneal and Pelvic Disease and remains a visiting consultant of the division of surgical oncology at NCCS.
Dr Teo completed her general surgical training in Singapore and was awarded the Health Manpower Development Plan scholarships by the Ministry of Health (MOH) for 2 fellowships in surgical oncology and colorectal surgery, where she built on her expertise in complex abdominal and pelvic surgery.
At NCCS, she co-chaired the sarcoma and melanoma workgroup and was a member of the gastrointestinal tract workgroup for the NCCS cancer service line. She was the chairperson for faculty affairs and professional development in the surgery academic clinical programme and was also the chairperson for the new NCCS building committee. She was also the director of strategic initiatives in the oncology academic clinical programme.
At the same time, she pursued clinical excellence, as well as clinical research and teaching. She was the principal investigator of more than 43 institutional review boards and has authored more than 250 peer-reviewed publications and 6 book chapters.
She has performed an average of 400 surgeries a year and has performed more than 10,000 gastroscopies and colonoscopies. She has been practising medicine for more than 20 years.
She is a member of the Singapore Society of Oncology. She also sits on the Singapore Cancer Network sarcoma guideline committee, and was a member of the MOH technology advisory committee. She continues to be an adjunct professor at DUKE-NUS Medical School.
Dr Teo is the recipient of numerous awards, including the SingHealth Service Excellence Award, Outstanding Faculty Award – Residency in SingHealth Excels (RiSE) Award in 2018 and Outstanding Faculty for Surgery – Duke-NUS Medical School in 2016.
Associated treatments
- Abdomen & the pelvis
- Laparoscopic cholecystectomy
- The Chest
- Endoscopic procedures
Awards and honours
- 2018
Outstanding Faculty Award – Residency in SingHealth Excels (RiSE) - 2016
Special Recognition Award for Role Model to Medicine Graduating Class, National University of Singapore
Outstanding Faculty for Surgery - 2015
SingHealth Excellence Award 2015 (Distinguished Young Leader Award)
Outstanding Faculty for Surgery
Fellowship and accreditation
Bachelor of Medicine, Bachelor of Surgery
Fellow of the Royal College of Surgeons of Edinburgh, UK
Master of Medicine (Surgery)
Master of Public Health, John Hopkins University, USA
Fellow of the Academy of Medicine, Singapore
Fellow of Toronto Surgical Oncology & Colorectal Fellowship Programmes
Contact Our Call Centre
RELATED ARTICLES
View all
CRS-HIPEC: An Innovative Treatment for Peritoneal Cancers
Take a dive into the world of CRS-HIPEC, an innovative two-step procedure that's able to treat peritoneal cancers.
Keep Your Health in Check after 40
As we age, our risk of cancer and other chronic diseases increase. Regular health screening helps pick up early signs of disease and can potentially save our lives.
